Menghan Du

419 total citations
11 papers, 295 citations indexed

About

Menghan Du is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Menghan Du has authored 11 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Menghan Du's work include CRISPR and Genetic Engineering (4 papers), RNA and protein synthesis mechanisms (3 papers) and Inflammasome and immune disorders (2 papers). Menghan Du is often cited by papers focused on CRISPR and Genetic Engineering (4 papers), RNA and protein synthesis mechanisms (3 papers) and Inflammasome and immune disorders (2 papers). Menghan Du collaborates with scholars based in China, United States and United Kingdom. Menghan Du's co-authors include Nathaniel Jillette, Albert W. Cheng, Jacqueline Jufen Zhu, Sheng Li, Aziz Taghbalout, Patricia A. Clow, Qinlu Zhang, Yali Cui, Lixia Zhang and Le Ma and has published in prestigious journals such as Nature Communications, International Journal of Molecular Sciences and European Journal of Pharmacology.

In The Last Decade

Menghan Du

10 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Menghan Du China 7 222 35 33 26 22 11 295
Christian Hauer Germany 7 248 1.1× 32 0.9× 20 0.6× 8 0.3× 10 0.5× 7 305
Tao Tao China 14 274 1.2× 17 0.5× 24 0.7× 13 0.5× 40 1.8× 31 391
Joel A. Morales‐Rosado United States 7 119 0.5× 21 0.6× 14 0.4× 18 0.7× 22 1.0× 16 206
Andrey S. Trulioff Russia 10 94 0.4× 32 0.9× 23 0.7× 7 0.3× 27 1.2× 26 316
Ziyao Wang China 10 197 0.9× 12 0.3× 31 0.9× 46 1.8× 11 0.5× 33 326
Minglei Yang China 13 205 0.9× 33 0.9× 24 0.7× 97 3.7× 20 0.9× 18 353
Yuang Wang China 12 239 1.1× 30 0.9× 56 1.7× 8 0.3× 12 0.5× 21 345
Stefanie Fischer Germany 7 272 1.2× 15 0.4× 37 1.1× 17 0.7× 17 0.8× 11 374

Countries citing papers authored by Menghan Du

Since Specialization
Citations

This map shows the geographic impact of Menghan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Menghan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Menghan Du more than expected).

Fields of papers citing papers by Menghan Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Menghan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Menghan Du. The network helps show where Menghan Du may publish in the future.

Co-authorship network of co-authors of Menghan Du

This figure shows the co-authorship network connecting the top 25 collaborators of Menghan Du. A scholar is included among the top collaborators of Menghan Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Menghan Du. Menghan Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hu, Yingying, Run Xu, Jing Feng, et al.. (2024). Identification of potential pathogenic hepatic super-enhancers regulatory network in high-fat diet induced hyperlipidemia. The Journal of Nutritional Biochemistry. 126. 109584–109584. 3 indexed citations
2.
Du, Menghan, et al.. (2024). Analyzing the Metabolic Destiny of Potentilla discolor Bge. Extract and Its Primary Components in Rat Models. Current Pharmaceutical Analysis. 20(7). 524–537.
3.
Tang, Pingping, Lin Yuan, Menghan Du, et al.. (2023). MiR‐203 improves cardiac dysfunction by targeting PARP1‐NAD+ axis in aging murine. Aging Cell. 23(3). e14063–e14063. 11 indexed citations
4.
Zhang, Qingwei, Ximing Chen, Yingying Hu, et al.. (2023). BIRC5 Inhibition Is Associated with Pyroptotic Cell Death via Caspase3-GSDME Pathway in Lung Adenocarcinoma Cells. International Journal of Molecular Sciences. 24(19). 14663–14663. 4 indexed citations
5.
Liu, Heng, Heyang Sun, Honglin Xu, et al.. (2023). Tetrahydroberberrubine prevents peritoneal adhesion by suppressing inflammation and extracellular matrix accumulation. European Journal of Pharmacology. 954. 175803–175803. 5 indexed citations
6.
Hu, Yingying, Shuqian Zhang, Menghan Du, et al.. (2023). Aloe-Emodin Derivative, an Anthraquinone Compound, Attenuates Pyroptosis by Targeting NLRP3 Inflammasome in Diabetic Cardiomyopathy. Pharmaceuticals. 16(9). 1275–1275. 9 indexed citations
7.
Clow, Patricia A., Menghan Du, Nathaniel Jillette, et al.. (2022). CRISPR-mediated multiplexed live cell imaging of nonrepetitive genomic loci with one guide RNA per locus. Nature Communications. 13(1). 1871–1871. 58 indexed citations
8.
Du, Menghan, Nathaniel Jillette, Jacqueline Jufen Zhu, Sheng Li, & Albert W. Cheng. (2020). CRISPR artificial splicing factors. Nature Communications. 11(1). 2973–2973. 88 indexed citations
9.
Taghbalout, Aziz, Menghan Du, Nathaniel Jillette, et al.. (2019). Enhanced CRISPR-based DNA demethylation by Casilio-ME-mediated RNA-guided coupling of methylcytosine oxidation and DNA repair pathways. Nature Communications. 10(1). 4296–4296. 40 indexed citations
10.
Jillette, Nathaniel, et al.. (2019). Split selectable markers. Nature Communications. 10(1). 4968–4968. 25 indexed citations
11.
Zhang, Qinlu, Qian Liu, Menghan Du, et al.. (2019). Cetuximab and Doxorubicin loaded dextran-coated Fe3O4 magnetic nanoparticles as novel targeted nanocarriers for non-small cell lung cancer. Journal of Magnetism and Magnetic Materials. 481. 122–128. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026